Bud Flagstad Appointed CEO of Care Angel

Bud Flagstad is a respected leader in the healthcare technology space where he most recently held the position of senior vice president of UnitedHealth Group Research & Development.

In this role, Bud Flagstad was responsible for driving consumer and provider engagement to reduce healthcare costs, increase access to high-quality care, enhance system efficiency and efficacy, and empower consumers to maintain or improve their health and wellbeing.

“After working with Bud as an investor and advisor to Care Angel for over a year, we are excited to welcome him to the Care Angel family as CEO,” said Wolf Shlagman, Care Angel founder and former CEO.  “The timing couldn’t be better to have him lead our revenue acceleration ramp and make sure we have the right partners to help fund our exponential growth. Bud has a proven track record and experience with some of the largest players in the market using transformative healthcare products that have impacted tens of millions of lives. I look forward to scaling the organization in collaboration with him.”

As the Care Angel model evolves, Mr. Shlagman will continue to play the vital role of developing the product vision as the chief product and innovation officer. “Wolf is well known for his heavy innovation experience, and his early contributions to building the framework of what the telemedicine industry is today,” said Care Angel chairman of the board, Patrick Byrne. Mr. Shlagman is a lifelong entrepreneur with 20+ years’ experience designing products and leading teams, is the founder of Consult A Doctor, which was acquired by Teladoc Health in 2013. “In his new role, Wolf will continue to leverage his deep technology knowledge as we deliver on the vision to deploy care at scale to the most at-risk populations globally.”

Over his prominent 30+ year career, Bud Flagstad has held executive leadership roles across the health insurance, private equity, medical startup and financial services industries. During his time at UnitedHealth Group specifically, a prestigious Fortune 50 company, he also spearheaded numerous projects, strategic partnerships and acquisitions.  Mr. Flagstad earned his Bachelor of Science in computer science and business administration at Minnesota State University.

“Working with Care Angel for over a year as both an investor and an advisor made it very apparent to me the potential impact the company can have on helping to build a better healthcare system with their solutions, supporting improved outcomes, reducing costs and expanding accessibility,” said Mr. Flagstad. “I truly look forward to joining such an incredible team.”

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.